Le Lézard
Classified in: Science and technology
Subject: Conference

Over 250 Attend Fasano Longevity Conference to Hear Broad Range of Topics


Over 250 longevity professionals attended the November 5th Fasano Longevity Conference to hear a broad range of topics affecting the longevity markets.

Chris Stroup, CEO of Wilton Re, keynoted the Conference with his Observations on Growth Amidst Evolving Opportunity.

The sessions included a presentation by longevity pioneer, Dr. David Blake, on the Investment Opportunities in the Risk Transfer Market, an evaluation by NASP Executive Director, Brian Dear, on the State of the Structured Settlement Market, and a call to action by Abacus CEO, Jay Jackson on the Current Dynamics of the Life Settlement Market.

The Conference also included original research, with a presentation by Northwestern University's Dr. Rick Morimoto, on the Molecular Determinants of Healthy Aging and a report by Dr. Mozziyar Etemadi on the results of a research project in which a Deep Learning model was able to detect malignant lung nodules on CT scans better than expert radiologists could.

Washington insiders, Jack Kelly and Michael Steele, added some controversy with their take on 2020 Presidential race, while Doug Fullam of AIR Worldwide ended the day with an eye opening presentation on the use of Artificial intelligence in Life and Annuity modeling.

Said Michael Fasano, President of Fasano Associates, "This year's Conference covered all segments of the longevity markets ? life settlements, structured settlements and pension risk transfer, while also presenting groundbreaking research on Deep Learning and the Biology of Aging." Fasano described his Conference as "Investor Focused". He added: "What sets our Conference apart is that we are able to get industry experts with fresh perspectives who can combine relevant experience with truly original research."

DVDs of the Conference are available (mfasano@fasanoassociates.com) for $595. Next year's Fasano Longevity Conference will be held on Monday, November 2nd in Washington, DC.

About Fasano Associates:

Fasano Associates is a leading underwriting consulting firm serving the life, health, annuity and life settlement industries.


These press releases may also interest you

at 16:35
AVROBIO, Inc. , a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today shared an update on its response to the COVID-19 pandemic and a current assessment of the impact on AVROBIO's...

at 16:30
An economic crisis can strike anytime, and the latest black swan event that we've entered is the best proof. Such an unpredictable and unforeseen event, unfortunately, comes with some extreme consequences, and people have to prepare for bleak times....

at 16:30
NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial results for the...

at 16:25
Canon U.S.A., Inc., a leader in digital imaging solutions, announced today that they will be hosting a Virtual Press Conference to unveil the company's new professional imaging products and technologies. The Virtual Press Conference, which will be...

at 16:15
QSC announces the opening of QSC Netherlands BV, effective April 1, 2020. Based in Geldermalsen, QSC Netherlands BV will serve as the business development hub for Live Sound & Systems in the Benelux region as well as house QSC's EMEA service repair...

at 16:15
INVO Bioscience, Inc. , a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced financial results...



News published on 7 november 2019 at 09:35 and distributed by: